Clinical Trials Sponsored by GLAXOSMITHKLINE BIOLOGICALS SA

Total 13 results

GlaxoSmithKline
iTeos Belgium SA

Recruiting

Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC)

Neoplasms

United States, Italy, Spain, France, Germany, Canada, Korea, Republic of, Netherlands, Poland, Romania, Russian Federation, Sweden
GlaxoSmithKline
iTeos Belgium SA

Completed

Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 1

Neoplasms

Spain, France, Poland, United States, Romania, Germany, Netherlands, Canada, Italy, Korea, Republic of, Russian Federation, Sweden
GlaxoSmithKline
Biological E. Limited

Recruiting

Safety and Immunogenicity of a Novel Conjugate Vaccine Against Salmonella Typhi and Salmonella Paratyphi A in Healthy Adults

Typhoid Fever

Belgium
LimmaTech Biologics AG
GlaxoSmithKline

Recruiting

Assessing the Safety, Immune Response, and Early Efficacy of a Candida Vaccine in Women With Recurrent Vulvovaginal Candidiasis: A Randomized Controlled Study

Recurrent Vulvovaginal Candidiasis

Belgium
LimmaTech Biologics AG
GlaxoSmithKline

Completed

Safety and Immunogenicity of a Klebsiella Pneumoniae Tetravalent Bioconjugate Vaccine (Kleb4V)

Klebsiella Pneumoniae Infection

Germany
iTeos Belgium SA
GlaxoSmithKline; iTeos Therapeutics

Recruiting

Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors (TIG-006)

Melanoma | Head and Neck Cancer | Lung Cancer | Advanced Cancer

Spain, Italy, France, United States, United Kingdom, Belgium
National Cancer Institute (NCI)
Glaxosmithkline Biologicals S.A.

Terminated

Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction

Renal Failure | Solid Neoplasm | BRAF Gene Mutation | Hepatic Complication

United States, Canada
iTeos Belgium SA
Bristol-Myers Squibb; GlaxoSmithKline; iTeos Therapeutics

Terminated

Study of Novel Regimens in Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

United States, France, Spain, Belgium
University of Birmingham
GlaxoSmithKline; Biotechnology and Biological Sciences Research Council

Completed

Dietary Correlates of the Maximal Capacity for Fat Oxidation

Maximal Rate of Fat Oxidation

United Kingdom
ANRS, Emerging Infectious Diseases
Bristol-Myers Squibb; GlaxoSmithKline; Roche Pharma AG; Schering-Plough; Merck Serono...

Completed

Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV (CO13Hepavih)

Hepatitis C | HIV
Eli Lilly and Company
GlaxoSmithKline; Shanghai Junshi Bioscience Co., Ltd.; Vir Biotechnology, Inc.; AbCellera Biologics Inc...

Completed

A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness (BLAZE-4)

COVID-19

United States, Puerto Rico, Argentina
PATH
GlaxoSmithKline; Kenya Medical Research Institute; US Army Medical Research Directorate-Africa... and other collaborators

Completed

RTS,S/AS01E Hypo-immuno-responsiveness Study

Plasmodium Falciparum

Kenya
Institut National de la Santé Et de la Recherche...
Assistance Publique - Hôpitaux de Paris; Cardiff University; Karolinska Institutet and other collaborators

Withdrawn

TINN2: Treat Infection in NeoNates 2 (TINN2)

Bronchopulmonary Dysplasia

Belgium, France, Germany, Hungary, Italy, Luxembourg, Netherlands, Sweden, United Kingdom

Clinical Trials Sponsored by GLAXOSMITHKLINE BIOLOGICALS SA

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Senegal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations